Anderson RM, Funnell MM. Patient empowerment: myths and misconceptions. Patient Educ Couns. 2010;79(3):277-82. Article
Bohnert AS, Bonar EE, Cunningham R, et al. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug Alcohol Depend. 2016;163:40-7. Abstract
Darker CD, Sweeney BP, Barry JM, et al. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database Syst Rev. 2015;(5):CD009652. Abstract
Fried TR, Mary E. Tinetti ME, Towle V. Effects of benefits and harms on older persons’ willingness to take medication for primary cardiovascular prevention. Arch Intern Med. 2011;171(10):923-8. Article
Galazzi A, Lusignani M, Chiarelli MT, et al. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. Int J Clin Pharm. 2016;38(2):454-61. Abstract
Gillespie R, Mullen J, Harrison L. Attitudes towards deprescribing and the influence of health literacy among older Australians. Primary Health Care Res Dev. 2019;20(e78):1-11. Abstract
Kalogianis MJ, Wimmer BC, Turner JP, et al. Are residents of aged care facilities willing to have their medications deprescribed? Res Social Adm Pharm. 2016;12(5):784-8. Abstract
Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2015;98(2):220-5. Abstract
Palagyi A, Keay L, Harper J, Barricades and brickwalls – a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr. 2016;16:15. Article
Reeve E, Wolff JL, Skehan M, et al. Assessment of attitudes toward deprescribing in older Medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673-80. Abstract
Reeve E, Wiese MD, Hendrix I, et al. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61(9):1508-14. Abstract
Warner NS, Habermann EB, Hooten WM, et al. Association between spine surgery and availability of opioid medication. JAMA Netw Open. 2020;3(6):e208974. Article
Mugunthan K, McGuire T, Glasziou P. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Br J Gen Pract. 2011;61(590):e573-8. Article
Atherton H, Sawmynaden P, Meyer B, Car J. Email for the coordination of healthcare appointments and attendance reminders. Cochrane Database Syst Rev. 2012;(8):CD007981. Abstract
Atherton H, Sawmynaden P, Sheikh A, et al. Email for clinical communication between patients / caregivers and healthcare professionals. Cochrane Database Syst Rev. 2012;11:CD007978. Abstract
Goyder C, Atherton H, Car M, et al. Email for clinical communication between healthcare professionals. Cochrane Database Syst Rev. 2015;(2):CD007979. Abstract
Meyer B, Atherton H, Sawmynaden P, Car J. Email for communicating results of diagnostic medical investigations to patients. Cochrane Database Syst Rev. 2012;(8):CD007980. Abstract
Advice by Postal Letter
Cormack MA, Sweeney KG, Hughes-Jones H, Foot GA. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract. 1994;44(378):5-8. Article
Cormack MA, Owens RG, Dewey ME. The effect of minimal interventions by general practitioners on long-term benzodiazepine use. J R Coll Gen Pract. 1989;39(327):408-11. Article
Darker CD, Sweeney BP, Barry JM, et al. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database Syst Rev. 2015;(5):CD009652. Abstract
de Gier NA, Gorgels WJ, Lucassen PL, et al. Discontinuation of long-term benzodiazepine use: 10-year follow-up. Fam Pract. 2011;28(3):253-9. Abstract
Gorgels WJ, Oude Voshaar RC, Mol AJ, et al. Consequences of a benzodiazepine discontinuation program in family practice on psychotropic medication prescription to the participants. Fam Pract. 2007;24(5):504-10. Article
Gorgels WJ, Oude Voshaar RC, Mol AJ, et al. Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. Fam Pract. 2006;23(1):65-72. Article
Gorgels WJ, Oude Voshaar RC, Mol AJ, et al. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend. 2005;78(1):49-56. Abstract
Guaiana G, Barbui C. Discontinuing benzodiazepines: best practices. Epidemiol Psychiatr Sci. 2016;25(3):214-6. Abstract
Heather N, Bowie A, Ashton H, et al. Randomized controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addiction Research Theory. 2009;12(2):141-54. Abstract
Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23(1):19-34. Abstract
Mol AJ, Oude Voshaar RC, Gorgels WJ, et al. The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial. Addict Behav. 2006;31(2):211-22. Abstract
Mugunthan K, McGuire T, Glasziou P. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Br J Gen Pract. 2011;61(590):e573-8. Article
Niessen WJ, Stewart RE, Broer J, Haaijer-Ruskamp FM. Reduction in the consumption of benzodiazepines due to a letter to chronic users from their own general practitioner. Ned Tijdschr Geneeskd. 2005;149(7):356-61. Abstract
Ten Wolde G, Dijkstra A, van Empelen P, et al. Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial. Addiction. 2008;103(4):662-70. Abstract
van de Steeg-van Gompel CH, Wensing M, De Smet PA. Implementation of a discontinuation letter to reduce long-term benzodiazepine use – a cluster randomized trial. Drug Alcohol Depend. 2009;99(1-3):105-14. Abstract
Vicens C, Sempere E, Bejarano F, et al. Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care. Br J Gen Pract. 2016;66(643):e85-91. Article
Voshaar RC, Couvée JE, van Balkom AJ, et al. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry. 2006;189:213-20. Article
de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, et al. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012;12:CD007459. Abstract
Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, et al. Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev. 2013;(12):CD007458. Abstract
Rees S, Williams A. Promoting and supporting self-management for adults living in the community with physical chronic illness: a systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter. JBI Libr Syst Rev. 2009;7(13):492-582. Abstract
Carlsen B, Aakvik A. Patient involvement in clinical decision making: the effect of GP attitude on patient satisfaction. Article
Hall DE, Prochazka AV, Fink AS. Informed consent for clinical treatment. CMAJ. 2012;184(5):533-40. Article
Massachusetts Bill H.4062 An Act relative to benzodiazepines and non-benzodiazepine hypnotics. Accessed 5/27/17
Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890-8. Article
Alexander GC, Casalino LP, Meltzer DO. Physician strategies to reduce patients’ out-of-pocket prescription costs. Arch Intern Med. 2005;165(6):633-6. Abstract
Shrank WH, Joseph GJ, Choudhry NK, et al. Physicians’ perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Am J Manag Care. 2006;12(9):545-51. Article
Disclaimer (Last updated: Febraurary 17, 2024) The information contained on tsrg.org website is for general information purposes only. The Schreiber Research Group does not take a policy position and reserves the right to make additions, deletions, or modification to the contents at any time without prior notice.
Images used under license from Shutterstock.com (Homepage, Blog, Contact Us, Donate, Our Team, Research, and Training). Artwork on the Benzodiazepine webpage was created by Akhtar Badshah (Kirkland, WA). The Benzo-Wise logo was created by Terri Schreiber and Salem Hansen (Aurora, CO).